Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer

Objectives: To explore whether Heberprot-P (an epidermal growth factor) is a cost-effective option for the treatment of advanced diabetic foot ulcer as an add-on therapy to good wound care (GWC) in Slovakia from the perspective of health care payers. Methods: A Markov model was constructed to compar...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Pharmacol
Main Authors: Tesar, Tomas, Szilberhorn, Laszlo, Nemeth, Bertalan, Nagy, Balazs, Wawruch, Martin, Kalo, Zoltan
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2017
Fag:
Pharmacology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5743698/
https://ncbi.nlm.nih.gov/pubmed/29311943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00946
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker